Rafael Cavalcante

Showing 1-13 of 13 articles

Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trial

Mancone M, Cavalcante R, Modolo R, Falcone M, Biondi-Zoccai G, Frati G, Spitzer E, Benedetto U, Blackstone E, Onuma Y, van Geuns R, Diletti R, Serruys P

April 17, 2020 | 10.4244/EIJ-D-19-00208

Coronary interventions

Prasugrel monotherapy after PCI with the SYNERGY stent in patients with chronic stable angina or stabilised acute coronary syndromes: rationale and design of the ASET pilot study

Kogame N, Modolo R, Tomaniak M, Cavalcante R, de Martino F, Tinoco J, Ribeiro E, Mehran R, Campos C, Onuma Y, Lemos P, Serruys P

August 9, 2019 | 10.4244/EIJ-D-19-00131

STEMI

Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial

Sotomi Y, Onuma Y, Liu S, Asano T, Eggermont J, Katagiri Y, Cavalcante R, de Winter R, Wykrzykowska J, Brugaletta S, Räber L, Sabaté M, Windecker S, Dijkstra J, Serruys P

August 24, 2018 | 10.4244/EIJ-D-17-00884

Difference in haemodynamic microenvironment in vessels scaffolded with Absorb BVS and Mirage BRMS: insights from a preclinical endothelial shear stress study

Tenekecioglu E, Torii R, Bourantas C, Sotomi Y, Cavalcante R, Zeng Y, Collet C, Crake T, Suwannasom P, Onuma Y, Serruys P

December 20, 2017 | 10.4244/EIJ-D-17-00283

Transcatheter aortic valve implantation for mixed versus pure stenotic aortic valve disease

Abdelghani M, Cavalcante R, Miyazaki Y, de Winter R, Tijssen J, Sarmento-Leite R, Mangione J, Abizaid A, Lemos P, Serruys P, de Brito Jr F

November 20, 2017 | 10.4244/EIJ-D-17-00328

Interventions for valvular disease

The interaction of de novo and pre-existing aortic regurgitation after TAVI: insights from a new quantitative aortographic technique

Tateishi H, Abdelghani M, Cavalcante R, Miyazaki Y, Campos C, Collet C, Slots T, Leite R, Mangione J, Abizaid A, Soliman O, Spitzer E, Onuma Y, Serruys P, Lemos P, de Brito Jr F

May 15, 2017 | 10.4244/EIJ-D-16-00647

Coronary interventions

Quantitative angiography methods for bifurcation lesions: a consensus statement update from the European Bifurcation Club

Collet C, Onuma Y, Cavalcante R, Grundeken M.J, Généreux P, Popma J, Costa R, Stankovic G, Tu S, Reiber J, Aben J, Lassen J, Louvard Y, Lansky A, Serruys P

May 15, 2017 | 10.4244/EIJ-D-16-00932

Coronary interventions

Pressure-mediated versus pharmacologic treatment of radial artery spasm during cardiac catheterisation: a randomised pilot study

Collet C, Corral J, Cavalcante R, Tateishi H, Belzarez O, Costa J, Costa R, Chamié D, Onuma Y, de Winter R, Abizaid A, Serruys P

April 7, 2017 | 10.4244/EIJ-D-16-00868

Coronary interventions

Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial

Cavalcante R, Onuma Y, Sotomi Y, Collet C, Thomsen B, Rogers C, Zeng Y, Tenekecioglu E, Asano T, Miyazaki Y, Abdelghani M, Morel M, Serruys P

March 20, 2017 | 10.4244/EIJ-D-16-00612

Coronary interventions

Quantification by optical coherence tomography imaging of the ablation volume obtained with the Orbital Atherectomy System in calcified coronary lesions

Sotomi Y, Cavalcante R, Shlofmitz R, Suwannasom P, Tateishi H, Tenekecioglu E, Zheng Y, Abdelghani M, de Winter R, Wykrzykowska J, Onuma Y, Serruys P

October 20, 2016 | 10.4244/EIJV12I9A184

Coronary interventions

Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?

Sotomi Y, Onuma Y, Suwannasom P, Tateishi H, Tenekecioglu E, Zeng Y, Cavalcante R, Jonker H, Dijkstra J, Foin N, Koon J, Collet C, de Winter R, Wykrzykowska J, Stone G, Popma J, Kozuma K, Tanabe K, Serruys P, Kimura T

October 10, 2016 | 10.4244/EIJV12I8A163

Coronary interventions

Periprocedural myocardial infarction in stent trials: how universal is the third universal definition?

Cavalcante R, Serruys P

September 18, 2016 | 10.4244/EIJV12I7A133

Coronary interventions

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

Escaned J, Banning A, Farooq V, Echavarría-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein A, Taggart D, Morel M, Van Es G-A, Serruys P

June 10, 2016 | 10.4244/EIJV12I2A36

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...